Response to 'The use of tenofovir in patients with COVID-19'.

Lee, Ming Jie; Nori, Achyuta; Fidler, Sarah; Kulasegaram, Ranjababu; Fox, Julie; Smith, Colette

Lee, Ming Jie; Nori, Achyuta; Fidler, Sarah; Kulasegaram, Ranjababu; Fox, Julie; Smith, Colette.

Lee MJ; Imperial College London, Department of Infectious Disease, and Imperial College NHS Trust, London, UK.
Nori A; Harrison Wing, Guys' and St Thomas' NHS Foundation Trust, London, UK.
Fidler S; Harrison Wing, Guys' and St Thomas' NHS Foundation Trust, London, UK.
Kulasegaram R; Imperial College London, Department of Infectious Disease, and Imperial College NHS Trust, London, UK.
Fox J; Harrison Wing, Guys' and St Thomas' NHS Foundation Trust, London, UK.
Smith C; Harrison Wing, Guys' and St Thomas' NHS Foundation Trust, London, UK.

HIV Med ; 23(8): 929-930, 2022 09.

Article in English | MEDLINE | ID: covidwho-1704453

Subject(s)

COVID-19 Drug Treatment; HIV Infections; Antiviral Agents/therapeutic use; HIV Infections/drug therapy; Humans; Lamivudine/therapeutic use; Tenofovir/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: Hiv.13278

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google